跳至主要内容
临床试验/NCT00312520
NCT00312520已完成3 期

The Efficacy and Safety of Intravenous Pulse Steroids Compared to Standard Oral Steroids in the Treatment of Problematic Hemangiomas in Infants: A Randomized Controlled Trial

The Hospital for Sick Children2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2002年7月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
20
试验地点
2
主要终点
Percent improvement in the appearance of hemangioma

研究概览

简要总结

The purpose of the study is to determine if pulse steroids are more efficacious and safer than the standard treatment with oral corticosteroids.

详细描述

Currently there is no prospective study in hemangioma patients answering critical questions such as: which type of steroid should be used,how much should we use and for how long. This study is an investigator blinded study with two arms:one arm is receiving standard treatment with daily oral corticosteroids and the other is receiving intravenous pulse corticosteroids daily for 3 days, monthly for 3 months. The main outcome of the study is assess the efficacy of each treament modality as the percentage improvement in the hemangioma's appearance. The secondary outcomes are the safety profiles of the two drugs and the changes in the angiogenesis markers as a result of treatment intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single

入排标准

年龄范围
1 Month 至 4 Months(Child)
性别
All
接受健康志愿者

入选标准

  • problematic facial hemangiomas (periorbital/facial hemangiomas with potential visual obstruction, large/dysfiguring hemangiomas)
  • 1-4 months of age
  • signed consent form

排除标准

  • refusal to participate
  • age > 4 months
  • complicated nonvisible hemangiomas
  • congenital heart disease

结局指标

主要结局

Percent improvement in the appearance of hemangioma

次要结局

  • Frequency of side-effects experienced by the patients
  • Changes in the angiogenesis markers

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elena Pope

Head, Section of Dermatology

The Hospital for Sick Children

研究点 (2)

Loading locations...

相似试验